ALLMedicine™ Clostridium Difficile Infection Center
Research & Reviews 4,979 results
https://doi.org/10.1080/17512433.2021.1890582
Expert Review of Clinical Pharmacology; Lee P, Fike D et. al.
Feb 12th, 2021 - Background: Proton pump inhibitor (PPI) exposure is associated with Clostridium difficile infection (CDI). The impact of the route of administration is unknown. Patients in the Multiparameter Intelligent Monitoring in Intensive Care II database (M...
https://doi.org/10.1007/s10620-021-06857-y 10.1177/1756284818777943 10.1177/2042098618809927 10.1053/j.gastro.2019.05.056 10.1038/ajg.2012.179 10.1016/j.cgh.2009.12.022 10.1111/nmo.12516 10.15403/jgld.2014.1121.252.iwg 10.3748/wjg.v20.i38.13999 10.14309/ajg.0000000000000504 10.1007/s10620-006-9306-y 10.1111/j.1572-0241.2008.01992.x 10.1186/s12866-019-1617-1 10.1007/s10620-020-06173-x 10.1371/journal.pone.0234906 10.1093/nar/gks808 10.1038/ajg.2017.46 10.1371/journal.pcbi.1003531 10.1186/s40168-017-0237-y 10.1038/ismej.2015.235 10.1001/jamainternmed.2013.14673 10.1186/s13054-016-1305-6 10.4103/2319-4170.128002 10.1017/ice.2016.194 10.1007/s10620-018-5122-4 10.1038/s41467-019-14177-z 10.1016/j.archoralbio.2019.104578
Digestive Diseases and Sciences; Weitsman S, Celly S et. al.
Feb 3rd, 2021 - Proton pump inhibitor (PPI) use is extremely common. PPIs have been suggested to affect the gut microbiome, and increase risks of Clostridium difficile infection and small intestinal bacterial overgrowth (SIBO). However, existing data are based on...
https://doi.org/10.1093/cid/ciaa1902
Clinical Infectious Diseases : an Official Publication Of... Lee JD, Heintz BH et. al.
Dec 31st, 2020 - Empiric antimicrobial therapy for healthcare-acquired infections often includes vancomycin plus an antipseudomonal beta-lactam (AP-BL). These agents vary in risk for adverse events, including acute kidney injury (AKI) and Clostridium difficile inf...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773277
PloS One; Inatomi T, Otomaru K
Dec 30th, 2020 - Infectious diseases are a threat to elderly individuals, whose immune systems weaken with age. Among the various infectious diseases, Clostridium difficile infection is associated with a high rate of mortality in elderly individuals and is a serio...
https://doi.org/10.1177/0003134820973720
The American Surgeon; Baker SE, Monlezun DJ et. al.
Dec 28th, 2020 - Clostridium difficile infection (CDI) is now the most common cause of healthcare-associated infections, with increasing prevalence, severity, and mortality of nosocomial and community-acquired CDI which makes up approximately one third of all CDI....
Guidelines 33 results
https://journals.lww.com/jpgn/Fulltext/2019/01000/Fecal_Microbiota_Transplantation_for_Recurrent.25.aspx
Davidovics,Z.,et al
Jan 21st, 2019 - Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice. With our increasing recognition of the critical rol...
https://doi.org/10.1016/j.jhin.2018.07.037
The Journal of Hospital Infection; Mullish BH, Quraishi MN et. al.
Sep 3rd, 2018 - The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|20...
http://ascopubs.org/doi/full/10.1200/JCO.18.00407
Diorio, C.
Aug 31st, 2018 - The aim of this work was to develop a clinical practice guideline for the prevention and treatment of Clostridium difficile infection (CDI) in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation (HSCT) patients.
https://doi.org/10.1136/gutjnl-2018-316818
Gut Mullish BH, Quraishi MN et. al.
Aug 29th, 2018 - Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies ...
https://gut.bmj.com/content/early/2018/08/27/gutjnl-2018-316818
Mullish, B.
Aug 27th, 2018 - Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies.
Drugs 4 results see all →
Clinicaltrials.gov 5,435 results
https://doi.org/10.1080/17512433.2021.1890582
Expert Review of Clinical Pharmacology; Lee P, Fike D et. al.
Feb 12th, 2021 - Background: Proton pump inhibitor (PPI) exposure is associated with Clostridium difficile infection (CDI). The impact of the route of administration is unknown. Patients in the Multiparameter Intelligent Monitoring in Intensive Care II database (M...
https://doi.org/10.1007/s10620-021-06857-y 10.1177/1756284818777943 10.1177/2042098618809927 10.1053/j.gastro.2019.05.056 10.1038/ajg.2012.179 10.1016/j.cgh.2009.12.022 10.1111/nmo.12516 10.15403/jgld.2014.1121.252.iwg 10.3748/wjg.v20.i38.13999 10.14309/ajg.0000000000000504 10.1007/s10620-006-9306-y 10.1111/j.1572-0241.2008.01992.x 10.1186/s12866-019-1617-1 10.1007/s10620-020-06173-x 10.1371/journal.pone.0234906 10.1093/nar/gks808 10.1038/ajg.2017.46 10.1371/journal.pcbi.1003531 10.1186/s40168-017-0237-y 10.1038/ismej.2015.235 10.1001/jamainternmed.2013.14673 10.1186/s13054-016-1305-6 10.4103/2319-4170.128002 10.1017/ice.2016.194 10.1007/s10620-018-5122-4 10.1038/s41467-019-14177-z 10.1016/j.archoralbio.2019.104578
Digestive Diseases and Sciences; Weitsman S, Celly S et. al.
Feb 3rd, 2021 - Proton pump inhibitor (PPI) use is extremely common. PPIs have been suggested to affect the gut microbiome, and increase risks of Clostridium difficile infection and small intestinal bacterial overgrowth (SIBO). However, existing data are based on...
https://doi.org/10.1093/cid/ciaa1902
Clinical Infectious Diseases : an Official Publication Of... Lee JD, Heintz BH et. al.
Dec 31st, 2020 - Empiric antimicrobial therapy for healthcare-acquired infections often includes vancomycin plus an antipseudomonal beta-lactam (AP-BL). These agents vary in risk for adverse events, including acute kidney injury (AKI) and Clostridium difficile inf...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773277
PloS One; Inatomi T, Otomaru K
Dec 30th, 2020 - Infectious diseases are a threat to elderly individuals, whose immune systems weaken with age. Among the various infectious diseases, Clostridium difficile infection is associated with a high rate of mortality in elderly individuals and is a serio...
https://doi.org/10.1177/0003134820973720
The American Surgeon; Baker SE, Monlezun DJ et. al.
Dec 28th, 2020 - Clostridium difficile infection (CDI) is now the most common cause of healthcare-associated infections, with increasing prevalence, severity, and mortality of nosocomial and community-acquired CDI which makes up approximately one third of all CDI....
News 641 results
https://www.staging.medscape.com/viewarticle/922705
Dec 16th, 2019 - Although fecal microbiota transplantation (FMT) has not yet received approval from the US Food and Drug Administration (FDA), more than 10,000 patients receive FMT in the United States each year to treat Clostridium difficile infection, and hundre...
https://www.mdedge.com/fedprac/article/202170/health-policy/probiotic-use-prevention-antibiotic-associated-clostridium/page/0/1?channel=112
Jun 3rd, 2019 - Review of Probiotoc Literature Conflicting data exist about probiotics and their effect on CDI prevention. The literature reviewed was selected based on our assessment of its contribution to the topic and its potential utility to clinicians in det.
https://www.mdedge.com/familymedicine/article/200745/obesity/fmt-explored-potential-weight-loss-treatment?channel=39313
MDedge Endocrinology; Doug Brunk
May 12th, 2019 - Performing fecal microbiota transplantation in medically uncompromised obese individuals did not result in weight loss nor an increase of the gut hormone glucagon-like peptide 1 (GLP-1) at 12 weeks, but it did contribute to a decrease in primary b.
https://www.medpagetoday.com/infectiousdisease/infectioncontrol/79413
Apr 24th, 2019 - Longer duration of antibiotic prophylaxis after major surgery was associated with higher odds of acute kidney injury (AKI) and higher odds of Clostridium difficile infection, researchers found. There was a duration-dependent relationship between o...
https://www.staging.medscape.com/viewarticle/908735
Feb 5th, 2019 - Could fecal microbiota transplantation (FMT), whereby medical-processed stool material from a healthy donor is introduced into the intestine of a patient with obesity, be one of the answers to tackling this disease? That is the belief of several g...